✦ LIBER ✦

Monotherapy with low-dose thalidomide for relapsed or refractory multiple myeloma: better response rate with earlier treatment

✍ Scribed by Vladimír Maisnar; Jakub Radocha; Tomáš Büchler; Václav Bláha; Jaroslav Malý; Roman Hájek

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Assessing response rates in clinical tri

✍ Prince, H M; Schenkel, B; Mileshkin, L 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 83 KB

Intermediate-dose (25 mg/m2) intravenous

✍ M. T. Petrucci; G. Avvisati; Dr. M. Tribalto; M. Cantonetti; P. Giovangrossi; F. 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 283 KB

Improved response with post-ASCT consoli

✍ Neil Rabin; Laura Percy; Iftekhar Khan; John Quinn; Shirley D'Sa; Kwee L. Yong 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 228 KB

Assessing response rates in clinical tri

✍ Durie, B G M; Rajkumar, S V 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 50 KB

A comparison of bortezomib, cyclophospha

✍ Ahn, Jae-Sook; Yang, Deok-Hwan; Jung, Sung-Hoon; Park, Hyung Chul; Moon, Joon Ho 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 224 KB

A phase I study of bortezomib in combina

✍ Yasushi Takamatsu; Kazutaka Sunami; Hiroyuki Hata; Koji Nagafuji; Ilseung Choi; 📂 Article 📅 2010 🏛 Carden Jennings Publishing 🌐 English ⚖ 167 KB